Senior insider sale
Chief Financial Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$204.9K
22.94K shares
What this filing means
NOTMAN DONALD plans to sell 22.94K shares of OCULAR THERAPEUTIX, INC valued at approximately $204.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/12/2026ACC: 0001950047-26-001225
Officer· Chief Financial Officer
Since Aug 2018
22.94K
Shares to sell
$204.9K
Approx. market value
11.45K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
2/11/2026
11.45KTotal acquired11.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/11/2026 | Restricted stock vesting under a registered plan Not Applicable | 11.45K | — |
| Total | 11.45K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
6.04K
Market value
$51.5K
2/4/2026
—Completed
Units to sell
5.46K
Market value
$49.9K
2/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.45K
Market value
$103.5K
2/12/2026
Total
Units
22.94K
Value
$204.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 6.04K | $51.5K | — | Completed |
2/2/2026 | 5.46K | $49.9K | — | Completed |
| Planned — Approximate Date | ||||
2/12/2026 | 11.45K | $103.5K | NASDAQ | Planned |
| Total | 22.94K | $204.9K | ||